Impact of the revised FIGO 2018 staging system on survival outcomes with respect to prognostic factors in cervical cancer patients treated in a tertiary care cancer center in South Karnataka

Puntos clave

• This research examines how the revised FIGO 2018 staging system influences survival outcomes in cervical cancer patients.
• Analyzed survival data of cervical cancer patients treated at a tertiary care cancer center.
• Compared outcomes across different FIGO stages, particularly focusing on IIIC1, IIIB, IIIC2, and IVA.
• Identified prognostic factors associated with survival variations.
• Stage IIIC1 exhibited better survival outcomes than stage IIIB.
• Stage IIIC2 demonstrated worse outcomes compared to stage IVA.
• Variability in survival by stage underscores the need for improved treatment strategies, especially for node-positive disease.